Traumatic microbleeds are small foci of hypointensity seen on T 2 Ã -weighted MRI in patients following head trauma that have previously been considered a marker of axonal injury. The linear appearance and location of some traumatic microbleeds suggests a vascular origin. The aims of this study were to: (i) identify and characterize traumatic microbleeds in patients with acute traumatic brain injury; (ii) determine whether appearance of traumatic microbleeds predict clinical outcome; and (iii) describe the pathology underlying traumatic microbleeds in an index patient. Patients presenting to the emergency department following acute head trauma who received a head CT were enrolled within 48 h of injury and received a research MRI. Disability was defined using Glasgow Outcome Scale-Extended 46 at follow-up. All magnetic resonance images were interpreted prospectively and were used for subsequent analysis of traumatic microbleeds. Lesions on T 2 Ã MRI were stratified based on 'linear' streak-like or 'punctate' petechial-appearing traumatic microbleeds. The brain of an enrolled subject imaged acutely was procured following death for evaluation of traumatic microbleeds using MRI targeted pathology methods. Of the 439 patients enrolled over 78 months, 31% (134/439) had evidence of punctate and/or linear traumatic microbleeds on MRI. Severity of injury, mechanism of injury, and CT findings were associated with traumatic microbleeds on MRI. The presence of traumatic microbleeds was an independent predictor of disability (P 5 0.05; odds ratio = 2.5). No differences were found between patients with punctate versus linear appearing microbleeds. Post-mortem imaging and histology revealed traumatic microbleed co-localization with iron-laden macrophages, predominately seen in perivascular space. Evidence of axonal injury was not observed in co-localized histopathological sections. Traumatic microbleeds were prevalent in the population studied and predictive of worse outcome. The source of traumatic microbleed signal on MRI appeared to be iron-laden macrophages in the perivascular space tracking a network of injured vessels. While axonal injury in association with traumatic microbleeds cannot be excluded, recognizing traumatic microbleeds as a form of traumatic vascular injury may aid in identifying patients who could benefit from new therapies targeting the injured vasculature and secondary injury to parenchyma.
Introduction
Approximately 2.5 million individuals were seen in emergency departments for traumatic brain injuries (TBIs) in the USA in 2013 (Taylor et al., 2017) , with more unaccounted for due to mild injuries not requiring immediate medical attention. While most patients with TBI recover completely within weeks to months of their injury, over 3 million individuals are living with TBI-related disability in the USA (Thurman et al., 1999; Selassie et al., 2008; . The lack of understanding of the underlying pathophysiology of TBI and heterogeneity of the injury has made it difficult to find factors other than severity of injury that reliably predict clinical outcome, particularly in patients with mild TBI. Discovery of biomarkers that can identify the underlying pathology of TBI in living patients would be useful for diagnosis, prognosis, identifying therapeutic targets, stratifying patients for clinical interventions, and improving patient outcomes.
MRI allows rapid and precise localization of macroscopic damage across the injured brain. Some imaging abnormalities, such as extra-axial haemorrhage, have direct implications for the management of patients. Other abnormalities seen in patients after TBI are more difficult to interpret or determine whether they are indicative of more severe underlying damage not visible on MRI. An example is the small, often punctate hypointensities observed on T 2 Ã -weighted imaging, which have been observed in TBI patients after injury and in some cases found to correlate with clinical outcomes (Babikian et al., 2005; Colbert et al., 2010; Beauchamp et al., 2013; Yuh et al., 2013; Izzy et al., 2017) . On T 2 Ã -weighted sequences, these traumatic microbleeds (TMBs) appear as punctate (Tong et al., 2003; Huang et al., 2015; Lawrence et al., 2017) or linear (Ricciardi et al., 2017) hypointensities secondary to the accumulation of ferromagnetic or paramagnetic substances, presumably originating from haemoglobin in blood or residual haemosiderin in the grey and white matter.
The literature surrounding TMBs in TBI is complicated by the wide range of terminology used to described them. For instance, they have been referred to as haemorrhagic diffuse axonal injury (Babikian et al., 2005) , foci of haemorrhagic axonal injury (Yuh et al., 2013; Liu et al., 2014) , haemorrhagic traumatic punctate lesions (Geurts et al., 2012; Spitz et al., 2013) , haemorrhage in supratentorial white matter on T 2 Ã -weighted MRI (Iwamura et al., 2012) , T 2 Ã -weighted lesions (Beauchamp et al., 2013) , cerebral microhaemorrhage (Colbert et al., 2010) , and TMBs (Toth et al., 2016; Izzy et al., 2017) .
The clinical significance of TMBs is limited, in part, by the absence of radiological-pathological comparison to determine the cellular changes underlying signal abnormalities observed on MRI. While equating petechial blood seen on MRI to diffuse axonal injury (which is difficult to detect radiologically) may be appropriate in patients traditionally classified as severely injured, the association has yet to be established at the mild end of the spectrum of injury. The relationship is further confounded because the appearance of TMBs and severity of injury covary, making it difficult to determine whether TMBs are simply a signature of more severe injury or whether they could be causally associated with worse outcome. Additionally, studies have examined the prevalence of TMBs in patients during the chronic phase of disease where it can be difficult to distinguish them from non-traumatic microbleeds associated with small vessel disease (Conijn et al., 2011) , ageing (Fisher et al., 2010) and ischaemic stroke (Naka et al., 2004) .
Previously, our group examined TMBs in the acute phase of TBI and stroke and found linear-appearing TMBs to be present only in patients with TBI, suggesting that at least linear TMBs are consistent with trauma and might be the result of injured vessels (Ricciardi et al., 2017) . Such linear TMBs are best visualized with the assistance of improved MRI parameters, including a 3D T 2 Ã -weighted sequence, which can identify what initially appears to be punctate hypointensities on sequential axial slices to be connected in a linear shape. Based on the elongated appearance and frequent location and orientation similar to that of venous structures, we conjecture that TMBs seen on MRI may be a form of traumatic vascular injury distinct from primary injury to the axons.
During the conduct of an observational imaging-based study, a subject with linear TMBs detected in the hyperacute setting later expired, presenting an opportunity to study the pathology underlying a signature MRI finding in TBI patients. The aims of this study were to: (i) identify and characterize TMBs in a population of patients with acute and primarily mild TBI; (ii) determine whether the presence or type of TMB predicted patient outcomes; and (iii) characterize the pathology underlying TMBs in an index patient. We used MRI guided post-mortem sectioning (Absinta et al., 2014; Van Veluw et al., 2013 , 3D reconstruction of histological sections (Lee et al., 2018) , and post-mortem imaging methods to correlate pathological and radiological findings directly.
Materials and methods
This prospective study was approved by the Institutional Review Boards of the National Institutes of Health, Uniformed Services University of the Health Sciences and MedStar Washington Hospital Center, along with the Johns Hopkins Suburban Hospital Privacy Board. Written informed consent was obtained prior to all study procedures in accordance with the Declaration of Helsinki.
Patient population and study design
Patients presenting to the emergency department at level I (Medstar Washington Hospital Center) and level II (Johns Hopkins Suburban Hospital) trauma centres in the Washington, DC metropolitan area with (i) documented mechanism of trauma to the head; or (ii) suspicion of head injury concerning enough to trigger a CT for clinical purposes, were screened for enrolment in an observational protocol; the Traumatic Head Injury Neuroimaging Classification (THINC) study (clinicaltrials.gov NCT01132937). A multiphase screening approach under a HIPAA waiver of authorization was used by research staff to screen all patients presenting to the emergency department for suspected TBI to avoid investigator bias or exclude patients who lacked a clinical diagnosis of TBI (Cota et al., 2018) . Written informed consent was obtained from the patients or their surrogates prior to any study procedures. Inclusion criteria were as follows: (i) 18 years of age or older; (ii) deemed medically safe for participation; and (iii) consent and ability to obtain a research MRI within 48 h of injury. Patients were excluded if they were psychiatrically unstable or had any contraindication to MRI, including claustrophobia and pregnancy. For each year during the course of this study, $4500 patients were screened for eligibility at two hospitals, 500 patients were approached for enrolment in the study and $95 patients enrolled. Patients enrolled over a 78-month period were retrospectively selected for this analysis with the following criteria: (i) met the American Congress of Rehabilitation Medicine diagnostic criteria for TBI (Menon et al., 2010) ; (ii) had a clinical CT of the head at presentation; and (iii) completed the research MRI at baseline with T 2 Ã -weighted image sequences that were interpretable.
Patients enrolled in this study were seen at up to four visits post-injury: (i) as soon as clinically permissible and 448 h; (ii) 1 week; (iii) 30 days; and (iv) 90 days. Research MRI at the hospital site, demographic information, emergency department intake measures [e.g. injury presentation; injury cause; evidence of loss of consciousness, altered mental status, and post-traumatic amnesia; Glasgow coma scale (GCS); injury symptoms assessed using the neurobehavioral symptom inventory (NSI); medications on admissions (including indication)] and history and risk factors were obtained during the first visit. A CT was obtained if medically necessary. Subsequent visits included a 3 T MRI, NSI, and clinical recovery assessment (Glasgow Outcome Scale-Extended, GOSE). For this analysis, we consider the imaging obtained at the baseline visit and outcomes obtained at the later available of 30-or 90day visits.
Imaging protocol
Over the duration of the study, MRIs were acquired on three types of scanners: a 1.5 T (Signa, GE Medical Systems) or a 3 T (Skyra, Siemens) at Suburban Hospital, and a 3 T (Achieva, Philips) at MedStar Washington Hospital Center. The MRI protocol was standardized from commercially available sequences and consisted of a diffusion tensor imaging (DTI) sequence with derived isotropic diffusion-weighted imaging and apparent diffusion coefficient map, T 2 Ã gradient recalled echo (GRE), 'increased TE' T 2 Ã susceptibility-weighted imaging (SWI), T 2 -FLAIR (fluid attenuated inversion recovery) and a 3D T 1 -weighted sequence. Parameters of sequences were adjusted to produce similar appearing contrast across field strength. The total duration of this research MRI protocol was $25 min. Additional parameters of T 2 Ã -weighted sequences can be found in Supplementary Table 1 .
Classification of imaging findings
A neuroradiologist at each site interpreted all CT and MRI exams, resulting in a report used for clinical decision making. In addition, all magnetic resonance images were interpreted prospectively for research purposes, assessed for evidence of acute TBI, stratified as outlined previously by Ricciardi and colleagues (2017) , and used for subsequent identification and analysis. TMBs were classified by presence of foci of hypointensity detected in the parenchyma first detectable on the GRE images, then confirmed on SWI series. We consider both traditional T 2 Ã gradient recalled echo, and higher resolution, 3D-T 2 Ã (sometimes referred to as SWI), with a longer echo time. Conspicuity of TMBs on MRI vary depending on the acquisition parameters. A conservative approach was taken to minimize the potential for overcalling where multiple contrast mechanisms (sequences) were reviewed to confidently identify and classify TMBs. Hypointense foci seen on SWI, but that could not also be confirmed on GRE, were not considered; i.e. to be classified as a microbleed, the lesion had to be visible on both scans when available. Other sequences, including high resolution 3D-T 1 -weighted spoiled gradient recalled acquisition and T 2 -FLAIR-weighted, were used to help confirm localization of TMBs localized to the parenchyma and specifically distinct from the extra-axial space. Following identification, TMBs were further stratified as either 'punctate' or 'linear' in appearance. Punctate TMBs were defined as circular appearing hypointensities seen in no more than two adjacent axial slices (i.e. 47 mm on T 2 Ã GRE), and further stratified as (i) any in number; or (ii) five or more in number ( Fig. 1A-C ). Linear TMBs were identified as linearappearing hypointensities extending for more than two adjacent axial slices (i.e. 47 mm on T 2 Ã GRE). SWI images were reconstructed in tri-planar angled oblique (tri-planar view) using minimum intensity projection thin-slab of $10 mm to aid in distinguishing linear from punctate classifications ( Fig.  1D-F ). Scans from one quarter of the population were independently interpreted by two raters to estimate inter-rater agreement using Cohen's kappa. Further, location of punctate and linear TMBs were scored and included in research MRI interpretation. Specifically, location of linear or punctate TMBs were categorized as appearing in either the prefrontal, temporal, parietal and/or occipital lobe, as well as in deep or infratentorial regions of the brain.
Statistical analysis
We first compared patients with and without TMBs to identify demographic features, injury characteristics, clinical presentation, cardiovascular risk factors and medications (which categorically included anticoagulants, antiplatelets, antihypertensive agents, and lipid lowering agents), and other imaging factors that may be predictive of their presence. In the subgroup of patients with GOSE available, we stratified patients as having good recovery (GOSE = 7 or 8) versus disability (GOSE 4 6). To determine clinical and demographic characteristics associated with disability after TBI, a binary logistic regression was performed. Included in the model were parameters determined to be significant in the univariate analysis including: trauma level, GCS, TBI diagnosis, time to MRI, parenchymal and/or extra-axial injury evident on CT, and presence of punctate TMBs, linear TMBs, or both ( Supplementary Table 3 ). Statistical analyses were conducted in Statistical Product and Service Solutions (SPSS) 16.0. The accepted level of significance was P 5 0.05.
Neuropathology case study

Index patient
To evaluate the underlying pathology of TMBs, we performed post-mortem MRI and histology on the brain of a patient imaged with magnetic resonance within 48 h of injury and having both punctate and linear-appearing TMBs. Upon death, the next of kin contacted the research team and expressed a willingness to donate the decedent's brain for research purposes. The donation presented a rare opportunity to target findings seen on acute in vivo research MRI with histology. Consent for unrestricted autopsy was obtained, the decedent was transported to the NIH Clinical Center, and the whole brain was procured through autopsy at a post-mortem interval of 21 h.
The patient was a middle-aged male found unresponsive after a bicycle accident, with a right subdural haemorrhage with marked midline shift seen on CT that prompted hemicraniectomy and evacuation within 2 h of injury, indicating severe TBI. Consent for participation was provided by a family surrogate. A 3 T MRI scan of the patient was obtained post-hemicraniectomy within 48 h of injury, and again at 1 week postinjury and 3 months post-injury. Multiple punctate and linear regions of hypointensity were conspicuous on T 2 Ã -weighted surfaces in the bilateral frontal lobes and in other regions of the brain. The patient died 7 months post-injury due to complications from sepsis. The patient had a previous history of remote head trauma and substance abuse. Medical records were obtained to aid in evaluating factors that may have contributed to antemortem injury.
Post-mortem MRI
Following procurement, whole brain was suspended in 10% formalin within a net and using a 'string' ligated to the basilar artery. A 3 T MRI was obtained immediately to confirm the presence of TMBs. The brain was maintained in 10% formalin to fix for 2 weeks and then switched to 1% diluted formalin solution. The fixed brain was placed in a custom-made MRI compatible holder and saturated with fluorinated oil (Fomblin, Solvay Specialty Polymers) that does not contain hydrogen protons visible on MRI. A vacuum was pulled for 2 h with a 1/3 horsepower vacuum pump, the oil outgassed while bubbles were noted to rise to the surface. A CT was obtained to confirm air bubbles were not present in the sulci or tissue.
The brain in the holder was transferred to a whole-body 7 T MRI scanner (Siemens) and imaged with a 32-channel receiver coil for $48 h. Two contrast mechanisms were used, a multiecho T 2 Ã -weighted (ME-GRE), and a FLASH inversion recovery T 1 -weighted sequence. Because of the size of the data, Traumatic microbleeds and vascular injury multiple thick slabs were used to cover the whole brain. The following parameters were used for the ME-GRE; repetition time = 60 ms, four echo times = 6.2, 12, 18 and 24 ms, field of view = 160 mm, 380 Â 380 voxels for 420 mm in-plane resolution, 88 axial-oblique slices, 420-mm thick for a coverage of 37 mm S-I, flip angle = 10 , total acquisition time of 136 min.
MRI to pathology co-registration and histology
The previously acquired in vivo 3 T MRI was used to identify sections containing TMBs and sections negative for TMBs. The 7 T whole brain MRI was used to confirm the location of the region of interest containing TMBs or excluding TMBs, and guide sectioning. The brain was then sectioned into standard histology slide-size ($2 Â 2 Â 3 cm) blocks or large ($2 Â 7.5 Â 12.5 cm) blocks containing possible regions of interest. Each of the standard sized blocks were imaged in a small-bore 7 T MRI at 100-mm isotropic resolution to confirm localization. The following parameters were used for the small-bore 3D multi-gradient echo (T 2 Ã -weighted) MRI sequence, repetition time = 50 ms, echo times = 5, 13, 21, 29 and 37 ms, NA = 10, field of view = 4.6 Â 3.6 Â 1.1 cm, matrix = 460 Â 360 Â 110, 100 mm isotropic in-plane resolution, with a total acquisition time of 297 min.
After MRI, tissue was blocked to fit onto standard large 3 Â 5 00 slides and standard 1 Â 3 00 slides. Eight blocks of tissue were obtained for histopathological analysis; one section targeted by MRI for absence of TMB (as a negative control) and seven targeted by MRI for presence of TMB. Of these, four blocks were processed using standard 2D histopathology methods and four were processed using tape-transfer histopathology, of which one blocked tissue was used for 3D reconstruction. Additional blocks were obtained and analysed using standard 2D histopathological analysis, one large-section block and three standard histology-sized (1 Â 3 00 ) blocks. Of these three blocks, one section was targeted by MRI as a more inferior section that was centimetres away from a TMB, and was used as a negative control. Blocked tissue was frozen and sectioned at 20 mm using a custom tape-transfer process, or paraffin embedded and sectioned at 8 mm (large format) or at 5 mm (standard 1 Â 3 0 ) using standard sectioning methods. Tissue was cryoprotected in grades of sucrose, embedded in Neg-50 TM (optimum cutting temperature compound) and frozen in isopentane. Tape-transfer sectioning techniques were accomplished through the use of an adapted cryostat sectioning method that preserved spatial registry and allowed later 3D reconstruction of the sample (Pinskiy et al., 2015) . Alternating sections were then stained using Gallyas silver, Nissl, and Perls Prussian Blue (Turtzo et al., 2013) and cover slips were mounted using DPX medium (Sigma-Aldrich). Additional sections were stained with haematoxylin and eosin and amyloid precursor protein (APP) and read by a neuropathologist for evidence of axonal injury. APP staining was done on a Leica Bond automated stainer using Amyloid Precursor Protein Polyclonal Antibody (Invitrogen PA1-37099, Thermo Fisher) at 1:100 dilution with citrate epitope retrieval. Slides were digitized using a digital slide scanner (NanoZoomer 2.0-HT; Hamamatsu Photonics) at 0.46 mm/ pixel; raw images were converted to lossless JPEG2000 files producing a 3 TB dataset of 550 images per sample. A volumetric brain stack was created by aligning all images within a frame of reference, via 2D rigid transformations (Lee et al., 2018) . This aligned 3D stack was processed further to produce a reconstructed sagittal, axial, and maximum intensity projection in each plane.
Data availability
The authors confirm that the data supporting the findings of this study are available from the corresponding author upon reasonable request.
Results
Patient demographics and clinical characteristics
Four hundred and thirty-nine patients enrolled during a 78-month time period met the inclusion criteria ( Supplementary Fig. 1 ) for initial analysis (Table 1 ). The population was 73% male with a median age of 46 [interquartile range (IQR): 29-58]. The most common cause of injury was road traffic accidents (47%), followed by incidental fall (37%) and violence or assault (11%). Most patients had mild TBI (83%); the average GCS score at time of admissions was 15 (IQR: [14] [15] the temporal lobe and 31 (34%) in the parietal lobe. Linear microbleeds were seen more frequently in the frontal and parietal lobes while no linear TMBs were observed in deep structures. Note, some patients showed evidence of punctate and linear TMBs that were observed in multiple locations. Demographic variables (Table 1) including age (P = 0.109), sex (P = 0.739), race (P = 0.118) and ethnicity (P = 0.266) did not differ between patients with and without TMBs. Injury severity (P 5 0.001), GCS at time of arrival (P = 0.021), injury cause (P = 0.029), and evidence of trauma on CT (P 5 0.001) were all significantly associated with TMBs. Patients with TMBs had more severe injury and lower GCS compared to patients without TMBs. Cardiovascular risk factors, like patient-endorsed history of hyperlipidaemia (P = 0.023), valvular disease (P = 0.030), and concomitant use of antiplatelet medications (P = 0.032), and patient-endorsed history of antiplatelet medications were associated with presence of TMBs (Table 1) . Other cardiovascular risk factors such as hypertension (P = 0.552), diabetes (P = 0.852), stroke (P = 0.405), or anticoagulant (P = 1), antihypertensive (P = 0.229), or lipid lowering (P = 0.066) concomitant medications were not associated with presence or absence of TMBs. Within the population of patients with evidence of punctate and/or linear TMBs, those with or without specifically linear TMBs did not differ for demographic variables including age (P = 0.406), sex (P = 0.702), race (P = 0.112) and ethnicity (P = 0.118) (data not shown). Emergency department intake variables such as GCS at admissions (P = 0.191), trauma level of hospital site (P = 0.270), injury cause (P = 0.446), time from injury to clinical CT (P = 0.655) and time from injury to research MRI (P = 0.411) also did not differ between patients with or without linear TMBs (data not shown). There was also no significant difference in outcome (GOSE; P = 0.973) in those with or without linear TMBs.
More than half of the patients (250/439, 55%) returned for follow-up at 30-or 90-days post-injury. The population with available outcome data was older, white in race, and had a larger fraction of patients with TMBs compared to the population that was lost to follow-up (Supplementary Table 2 ). Table 2 shows the demographic and clinical features that were predictive of outcome in univariate analysis. Factors including GCS at admission (P = 0.044), clinical diagnosis of TBI (P = 0.014), evidence of injury observed on clinical CT (P = 0.003) and time from injury to start of research MRI (P = 0.001) were significant univariate predictors of outcome, and were included in the binary logistic regression. Age (P = 0.355), sex (P = 0.436), injury cause (P = 0.840) and time from injury to clinical CT (P = 0.537) were not significant univariate predictors of outcome and were not included in the regression. In the binary logistic regression analysis ( Supplementary Table  3 ) presence of both linear and punctate TMBs remained a significant predictor of outcome [b = 0.908, P 5 0.05; odds ratio (OR) = 2.5]. Trauma-level of hospital site (b = 0.996, P 5 0.05; OR = 2.7) and time to MRI (b = À0.034, P 50.05; OR = 0.97) were also significant predictors of outcome.
Index neuropathology case: in vivo to ex vivo imaging characterization of traumatic brain injury Punctate and curvilinear hypointensities visualized on axial T 2 Ã -weighted MRI were observed to have linear shape on coronal view (Fig. 2) of index patients acute T 2 Ã -weighted 3 T MRI. The pattern of hypointensities observed on acute DWI images with corresponding low apparent diffusion coefficient appear to manifest in tissue surrounding punctate TMBs observed on axial T 2 Ã -weighted magnetic resonance images of the index and mild TBI patient (Fig. 2) , indicating cytotoxic oedema in tissue surrounding TMBs. Additional hypointense lesions visualized on FLAIR magnetic resonance images of the index and mild TBI patient, characteristic of vasogenic oedema, co-localize to the same region of tissue where TMBs are observed on axial T 2 Ã -weighted MRI. Punctate and curvilinear hypointensities visualized on axial T 2 Ã -weighted MRI were observed to have linear shape on coronal view (Fig. 2) of the index patient's acute T 2 Ã -weighted 3 T MRI. This pattern of hypointensities observed on acute T 2 Ã -weighted 3 T MRI taken within 48 h of injury was still visible at 101 days post-injury in the index patient (Fig. 3) . These hypointensities were also observed on post-mortem T 2 Ã -weighted 7 T MRI of the formalin fixed brain. Despite the severe nature of this patient's injury, the linear TMBs observed were similar to those in patients with mild injury (Fig. 2G-L) . Linear TMBs observed acutely on the in vivo MRI were also visible on the 101 days post-injury in vivo MRI and on post-mortem ex vivo T 2 Ã -weighted 7 T MRI of the formalin fixed brain (Fig. 3) . Higher resolution ex vivo imaging (7 T) revealed that the linear TMBs identified on 3 T in vivo MRI were hypointensities that extend from grey matter into white matter with a linear shape.
Post-mortem imaging and histopathological correlates of traumatic brain injury
An MRI-guided strategy was used to target specific regions of interest for tissue sectioning, as described in the methods. Using this approach, regions of the index brain that contained TMBs visible on post-mortem 7 T MRI were accurately aligned with corresponding tissue histology (Fig. 4) . TMBs seen on 7 T MRI were co-localized with areas of iron complexed as haemosiderin deposits in macrophages in the perivascular space surrounding a vessel (Fig. 4A-D) , which is $50 mm in diameter. Haemosiderin-laden macrophages were also observed in the perivascular space surrounding smaller vessels distally (Fig. 4B ). Collections of haemosiderinladen macrophages and some free iron were observed between the vessels and neuropil, in the perivascular space of large and small vessels ( Fig. 4B-D) . Focal loss of the neuropil with significant infiltration by activated macrophages is observed distally to regions of vascular injury. Additionally, we observed capillary proliferation and significant reactive astrocytosis surrounding the loss of neuropil and enlarged perivascular spaces in proximity to injured vessels, both characteristic of ischaemia. Nissl stained sections revealed a loss of cell bodies around linear structures consistent with iron signal co-localized along a vessel. Similarly, Gallyas silver staining showed reduced myelin as well as the absence of axonal injury pathology, including a lack of axonal spheroids or beading in the surrounding areas ( Fig. 4E-J) . In sections targeting TMBs, evidence of axonal injury pathology or axonal spheroids was also absent in haematoxylin and eosin and in APP stained sections ( Supplementary  Fig. 2) . In a region negative for TMB on in vivo and ex vivo MRI, haematoxylin and eosin and Perls stained sections were also negative for iron-laden macrophages but positive on APP, with occasional APP expression of axonal processes in white matter ( Supplementary Fig. 2) . The presence of iron-positive macrophages in 2D histology suggested vascular injury. A 3D volume reconstruction was used to examine the extent of iron-positive macrophages in the perivascular space along the extended vascular tree. High resolution 3D reconstructions of the Perls stained histology sections generated a minimum intensity projection across a stack of digitized serial tissue sections through the tissue block (Fig. 5) . The 3D reconstruction contained structures co-localized with ironladen macrophages. These structures branch and extend over distances of centimetres in a pattern similar to the shape of the vascular tree and the linear TMBs observed on MRI (Fig. 5) . Interleaved serial sections of the area of TMBs in tri-planar view revealed a territory of injured vasculature in areas visible on MRI as punctate and linear hypointensities.
Discussion
This work provides evidence that: (i) TMBs have a high prevalence in acute TBI, being identified in 31% of patients in our predominantly mild population; (ii) within those who had presence of TMBs, there were no significant demographic or clinical predictors between those who had linear TMBs versus those who did not; (iii) both punctate and linear TMBs are predictive of outcome; those with evidence of TMBs were twice as likely to have disability at 30-or 90-days post-injury; (iv) across injury severity, some punctate TMBs visualized on axial T 2 Ã -weighted imaging were often revealed as linear structures in the coronal plane; and (v) after co-localizing TMBs seen on in vivo MRI and post-mortem high-resolution MRI to histopathology, we found iron-laden macrophages in the perivascular space surrounding injured vasculature, suggesting TMBs are a form of traumatic vascular injury. TMBs are a common finding on MRIs of patients following TBI. The field currently associates TMBs to both severe injury and clinical outcomes (Babikian et al., 2005; Colbert et al., 2010; Beauchamp et al., 2013; Yuh et al., 2013; Izzy et al., 2017) . However, our data suggest that TMBs are not exclusive to moderate or severe TBI. We have identified TMBs in 27% of mild, 47% of moderate, and 58% of severe TBI patients. We found that patients with TMBs had more severe injury and lower GCS compared to patients without TMBs. While our results are consistent with other studies demonstrating a positive relationship between TMB prevalence and injury severity, we also found that TMBs are present in more than one quarter of our mild TBI patients. This finding is important because most studies on TMBs are conducted on patients with severe injury. Thus, TMBs are observed more frequently in patients with severe injury (Geurts et al., 2012; Riedy et al., 2016; Toth et al., 2016) , which has made it difficult to determine if TMBs alone can predict clinical outcome.
To investigate the clinical implications of TMBs further, we controlled for variables that are known to predict poor outcome (trauma level and trauma-related injury on CT) and found that TMBs were a significant independent predictor of outcome. Patients with evidence of both punctate and linear TMBs were twice as likely to have disability (GOSE 4 6) on follow-up. We defined good recovery as GOSE of 7 (lower good recovery) and 8 (upper good recovery) and poor recovery of 46 (upper moderate disability to death). Yuh and colleagues (2013) similarly found that TMBs were a significant predictor of poor outcome, although they defined good outcome to be GOSE of 8 and poor outcome as GOSE of 47. They also found an association between number of lesions and outcome, with patients having 54 TMBs three times as likely to have poor outcome compared to patients with 43 TMBs. Others similarly found an association between lesion load and clinical outcome (Spitz et al., 2013) . However, we found that multiple punctate TMBs seen in TBI patients at 3 T were visible in connected branching structures. Thus, perhaps the effect of lesion load may be attributed to double counting of the same injured vascular network.
Identifying the cellular changes responsible for hypointensities observed on T 2 Ã -weighted images is critical for discovering primary injury mechanisms and ultimately clinical significance. To date, identification of TMBs on gross pathology alone has been challenging (Tatsumi et al., 2008) .
Post-mortem pathology studies of patients with severe TBI have established a link between evidence of direct injury to the axons not visible on neuroimaging and punctate hypointense lesions seen on T 2 Ã -weighted MRI, particularly in the corpus callosum and the infratentorial structures (Adams et al., 1982; Onaya, 2002; Keene et al., 2018) . With recent interest in mild TBI, there has been a tendency to equate TMBs in mild patients with underlying axonal injury, although the evidence in the literature supporting this assertion remains ambiguous.
This study presents the application of MRI-guided pathology to investigate specific TBI-associated lesions. This direct radiological-pathological correlation of in vivo and ex vivo imaging presented a unique opportunity to characterize TBI-related lesions seen acutely (within 48 h) after injury and further characterize the morphology associated with those lesions with targeted histology. Specifically, we identified that microbleeds evident within 48 h of TBI remained stable for at least 100 days after injury on in vivo MRIs. The presence of microbleeds in the same area of the cortex on post-mortem 7 T MRIs signified that microbleeds seen in vivo are also observed ex vivo. Hypointensities on T 2 Ã -weighted images, tracking through grey to white matter, appeared blue on Perls Prussian blue staining and correspond to iron in haemosiderin deposits that form in macrophages in the perivascular space tracking along vessels. Most iron was observed in macrophages outside of the parenchyma, suggesting iron (blood) was extravasated outside of injured vessels. Nissl-and myelin-stained sections of the same region of interest revealed fewer cell bodies and showing iron-laden macrophages that co-localized with a vessel. These interleaved serial sections of the TMB in tri-planar view reveal a territory of injured vasculature in areas visible on MRI as punctate or linear hypointensities. Injury to the large vessel is indicated by confluent regions of iron-laden macrophages that create sufficient signal for detection on MRI. Injury to some of the other smaller vessels is only detected on post-mortem histology in a 3D reconstruction. The tri-planar view and high resolution identifies connectivity of the injured vessels ranging from large to small diameters.
reduced myelin in the area of the injury, consistent with cell loss and demyelination. This indicates that the parenchyma surrounding the vessel is also injured. Further, on haematoxylin and eosin-and Nissl-stained regions located distally to and surrounding the injured vasculature, we observed focal loss of the neuropil with significant infiltration by activated macrophages and enlarged perivascular spaces. Both pathologies are characteristic of ischaemia, and correlate to regions where we observe cytotoxic and vasogenic oedema on in vivo acute MRI. Visualizing TMBs on 3D reconstruction of 2D Prussian blue histology, we observed macrophages along small and large vessels throughout the vasculature, suggesting a linear structure that appears to be an injury not just to a single large vessel but to a vascular tree. Evidence of axonal injury was not observed in these co-localized sections. Histological examination revealed a more extensive territory of vascular damage as compared to what was observed in small-bore 7 T MRI.
Using MRI guided pathology, we identified that what appeared as a punctate TMB on MRI corresponds to iron-laden macrophages in the perivascular space surrounding a vascular tree that extends over centimetres. This was surprising, as based upon the small-bore 7 T MRI, we expected to see iron within the parenchyma; however, we found iron inside macrophages outside of the parenchyma between the vessel and neuropil, tracking alongside vessels. This signifies that the extent of injury is more extensive than indicated on MRI, which has consequences to cellular function over a larger area of brain. Our findings also suggest that punctate and linear TMBs may not be distinct entities, but the difference in shape may be an issue of resolution. This presents evidence in support of a vascular injury, as depicted in Fig. 5 . The mechanism of this injury could be due to parasagittal bridging veins and other vessels anchored to the meninges that are directly injured from the movement of the brain within the skull, leading to secondary brain injury, as depicted in Fig. 6 .
Our observations of vascular injury on in vivo and ex vivo MRI and in the underlying histopathology are consistent with and build on early pathological investigations of TBI. Historically, observations of what are now referred to as TMBs suggested that they may be due to underlying vascular injury (Oppenheimer, 1968; Tomlinson, 1970) . Post-mortem reports showing microscopic lesions in TBI patients have shown similar microglial clusters that are commonly found along a blood vessel, suggesting that these lesions are due to stretching and tearing of small vessels leading to tiny capillary haemorrhages (Oppenheimer, 1968) . Later studies, often in severe patients, have ascribed these findings as secondary to the focal shearing of axons resulting in diffuse axonal injury (Adams et al., 1982; Scheid et al., 2003 Scheid et al., , 2006 Babikian et al., 2005) . Even more recent studies in animals and humans have shown a connection of the signal abnormalities observed on T 2 Ã weighted MRI to injury to the vasculature (Iwamura et al., 2012; Glushakova et al., 2014; Kenney et al., 2016; Tagge et al., 2018) suggesting the injury causes tearing to the blood vessels and triggering bridging veins to rupture. Thus, some groups have speculated cerebrovascular pathology to be a mechanistic link between TBI and Alzheimer's disease (Ramos-Cejudo et al., 2018) . In the post-mortem analysis of human brains from individuals with a history of multiple TBI's, researchers commonly observe neurofibrillary tangles surrounding penetrating small cortical vessels (McKee et al., 2013 (McKee et al., , 2015 and identify it as a characteristic pathology of chronic traumatic encephalopathy. Interestingly, these pathologies appear as linear Figure 6 Traumatic vascular injury. Traditionally, TMBs have been described as markers for diffuse axonal injury. However, TMBs have not been characterized as a form of traumatic vascular injury. MRI and 3D histology identified an underlying pathology of TMBs to be an injury to not just a single vessel, but injury that extends to a vascular network. Injury to a large blood vessel causes iron deposition that is detectable on in vivo and ex vivo MRI (at 3 T and 7 T). Smaller vessels that form a broader vascular network with the larger vessels are missed in these magnetic resonance images. Highresolution 3D histology of iron deposits in macrophages identified more extensive vascular injury involving smaller vessels that connect to the larger injured vessel detected on MRI. The schematic above illustrates a model of this vascular injury pattern and potential levels of detection with MRI and histological approaches.
accumulations that extend from the surface of the brain to the grey-white junction and, on cross-sectional visualization, are observed as 'dot-shaped' or 'thread-like' clusters (McKee et al., 2013 'dot-shaped' or 'thread-like' clusters (McKee et al., , 2015 . We report haemosiderin-laden macrophages around penetrating vessels and microvessels that are visualized in similar shapes and manifestations.
The presence of TMBs may be a biomarker for vascularrelated interventions after TBI. The leakage of blood from damaged blood vessels can trigger an inflammatory response. Researchers have previously suggested that TMBs result from chronic blood-brain barrier disruption and delayed chronic microvascular damage, which produce toxic iron deposition and initiate continued neuroinflammation and demyelination of axons (Harting et al., 2008; Glushakova et al., 2014) . In addition to the damaged vessels themselves, the disruption of normal pathways of blood flow and the influx of inflammatory cells could result in secondary injury to the brain tissue as a result of ischaemia. We have shown in vivo acute MRI data of cytotoxic and vasogenic oedema surrounding TMBs, and post-mortem pathology data of focal loss of neuropil, infiltrating macrophages and enlarged perivascular spaces proximal to injured vasculature, indicative of secondary injury to the brain tissue surrounding vascular injury. Our data suggest that acute TMBs are associated with acute MRI diffusion-weighted changes like those well-described from acute stroke studies. Thus, we postulate that TMBs may be useful biomarkers for identifying TBI patients that may benefit in the acute phase from therapies aimed at minimizing acute ischaemic damage, or in the chronic phase, at improving microvascular cerebral blood flow (Zhang et al., 2006; Kenney et al., 2018) . The persistence of inflammatory cells triggered by these TMBs in the perivascular spaces may also impede fluid movement, which, if in humans is analogous to the glymphatic system critical for removing substrates from the brain as described in rodents (Glushakova et al., 2014) , may affect the build-up of substrates and lead to secondary injury in humans as well. TMBs may also serve as biomarkers for patients more likely to have these glymphatic flow system disruptions, facilitating the identification of appropriate patients for therapeutic clinical trials. For example, pharmacological agents suggested by other TBI investigators to act on the microvasculature to increase cerebral perfusion include sildenafil (Kenney et al., 2018) and beta blockers such as propranolol (Loftus et al., 2016) . In contrast, minocycline has the potential to reduce acute ischaemic injury through its effects on inflammation, blood-brain barrier, and oedema (Mizuma and Yenari, 2017) .
Our MRI guided pathology methods address the limitations of standard pathological analysis of TMBs by improving the detection on histology, identifying the underlying pathophysiology, and providing confidence in linking the mechanism of injury to radiological findings. This radiological-pathological analysis shows that what was previously considered as punctate on 3 T in vivo MRI appears to have a linear shape using high-resolution 7 T MRI, suggesting that punctate and linear TMBs may be the same vascular injury. The ability to unambiguously co-localize the same region of injury on imaging within interleaved serial section histology allowed us to identify and better visualize the extent of injury to the vasculature. The microscopic sequelae of TBI were more extensive than could be seen by conventional in vivo imaging.
There are some limitations to this study. The methodology used here tended a conservative rating of the presence and classification of TMBs. It is possible that a greater number or different classification would occur if one sequence was considered (SWI or GRE) blinded to the other sequences. We believe, however, a comprehensive review of the imaging study is more representative of how images are interpreted in routine clinical practice.
There is always potential for selection bias. It is not clear if the enrolled population is representative of all patients presenting to the emergency department with similar characteristics. Because study staff were not available 24-7, it is likely that patients discharged rapidly from the emergency department are underrepresented. Similarly, patients with greater severity of injury (head or polytrauma) or unable to provide self-consent are likely underrepresented. Further work is needed to estimate prevalence. The population ( Table 2) returning for follow-up is slightly different than the population who did not return ( Supplementary Table  1 ). Patients who were more severely injured, and with a greater number of TMBs, were more likely to return for follow-up compared to those who did not return. This could be indicative that the follow-up patients are representative of more symptomatic patients, and thus may indicate a selection bias. However, other groups have also reported greater attrition that did not appear to impact their correlation of TMBs with clinical outcome . Additionally, our study is limited to a single outcome variable. The GOSE is not capable of capturing subtle postconcussive symptoms. However, for the purposes of this study, it is reliable for identifying patients who have not recovered and have persistent debilitating symptoms. The GOSE is commonly used as the sole clinical outcome variable in clinical TBI studies (Scheid et al., 2003; Geurts et al., 2012; Liu et al., 2016) . The choice of GOSE as the primary clinical outcome is an oversimplification of the clinical sequela, including the impact of the injury on cognition. The lack of cognitive outcome measures limit the interpretability of the impact of TMB on more subtle function that may not be reflected in the global measure such as the GOSE. Future studies should include a range of outcome variables to investigate more subtle symptoms. Lastly, our pathological analysis is limited to one index patient who had a complicated clinical history and severe injury with subdural haemorrhage. While this is not ideal, our serial in vivo imaging protocol allows us to be confident that the observed TMBs are the result of the acute injury and remain stable from the chronic to post-mortem period. The TMBs in the index patient were on the contralateral side to the subdural haemorrhage and had the same pattern observed on the magnetic resonance images of mild patients. Clearly, future studies are needed to examine the pathophysiology of TMBs and cerebral microbleeds that are not trauma-related.
In conclusion, this study provides evidence that TMBs represent traumatic vascular injury, which is not exclusive to severe injury and is predictive of outcome. Of the 439 TBI patients in our population, 134 (30.5%) patients were positive for TMBs. Of the TMB positive population, 97 (72%) were mild TBI patients. After controlling for trauma-related confounding variables, we found that TMBs were a significant predictor of outcome. Patients with TMBs were twice as likely to have disability, with a GOSE of 46 on follow-up. This study also addresses the current debate of the underlying pathophysiology of TMBs. Based on current literature we expected to find axonal injury in sections corresponding with TMBs. While we found evidence of cell loss and demyelination on our histopathological analysis, findings such as axonal bulbs or APP-positive axonal processes consistent with axonal injury were not observed in TMB-positive sections. Using MRI-guided pathology, we identified that what appeared as a punctate TMB on MRI corresponds to iron-laden macrophages in the perivascular space surrounding a vascular tree that extends over centimetres. These patterns likely represent traumatic injury to the microvasculature, resulting in extravasation of erythrocytes into perivascular spaces along vascular trees. While we cannot rule out that patients with TMBs have co-existing diffuse axonal injury, we do conclude that traumatic vascular injury is a distinct phenotype of TMBs and may provide opportunities for new therapies.
